Verition Fund Management’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33,452
| Closed | -$134K | – | 2921 |
|
|
2025
Q1 | $134K | Buy |
33,452
+19,810
| +145% | +$79.4K | ﹤0.01% | 2460 |
|
|
2024
Q4 | $88.5K | Sell |
13,642
-24,300
| -64% | -$158K | ﹤0.01% | 2424 |
|
|
2024
Q3 | $210K | Buy |
37,942
+24,185
| +176% | +$134K | ﹤0.01% | 2166 |
|
|
2024
Q2 | $76.8K | Buy |
+13,757
| New | +$76.8K | ﹤0.01% | 2110 |
|
|
2023
Q4 | – | Sell |
-30,451
| Closed | -$168K | – | 1946 |
|
|
2023
Q3 | $168K | Buy |
+30,451
| New | +$168K | ﹤0.01% | 1667 |
|
|
2023
Q2 | – | Sell |
-78,392
| Closed | -$720K | – | 1973 |
|
|
2023
Q1 | $720K | Buy |
+78,392
| New | +$720K | 0.01% | 982 |
|